MedTrace Logo

A Trial of Digoxin Before Second-Trimester Abortion

NCT01047748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2013-05-01

No results posted yet for this study

Summary

The purpose of our study is to determine the optimum route for the injection of digoxin prior to second-trimester surgical abortion.

Conditions

  • Induced Abortion

Interventions

DRUG

intra-fetal digoxin injection

Single transabdominal injection of digoxin 1 mg into the fetus

DRUG

intra-amniotic digoxin injection

Single transabdominal injection of digoxin 1 mg into the amniotic fluid

Sponsors & Collaborators

Principal Investigators

  • Katharine O White, MD, MPH · Physicians for Reproductive Choice and Health

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047748 on ClinicalTrials.gov